Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials.
exercise
intermittent fasting
multiple sclerosis
obesity
type 2 diabetes
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
13 Sep 2021
13 Sep 2021
Historique:
received:
25
06
2021
revised:
06
09
2021
accepted:
06
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
19
11
2021
Statut:
epublish
Résumé
Intermittent fasting has become popular in recent years and is controversially presented as a possible therapeutic adjunct. A bibliographic review of the literature on intermittent fasting and obesity, diabetes, and multiple sclerosis was carried out. The scientific quality of the methodology and the results obtained were evaluated in pairs. Intermittent fasting has beneficial effects on the lipid profile, and it is associated with weight loss and a modification of the distribution of abdominal fat in people with obesity and type 2 diabetes as well as an improvement in the control of glycemic levels. In patients with multiple sclerosis, the data available are too scarce to draw any firm conclusions, but it does appear that intermittent fasting may be a safe and feasible intervention. However, it is necessary to continue investigating its long-term effects since so far, the studies carried out are small and of short duration.
Identifiants
pubmed: 34579056
pii: nu13093179
doi: 10.3390/nu13093179
pmc: PMC8469355
pii:
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Références
Metabolism. 2020 Oct;111:154336
pubmed: 32777443
JBI Database System Rev Implement Rep. 2018 Feb;16(2):507-547
pubmed: 29419624
Nutr Res. 2020 Mar;75:32-43
pubmed: 31955013
Curr Diab Rep. 2017 Oct 23;17(12):123
pubmed: 29063418
Metab Syndr Relat Disord. 2020 Dec;18(10):450-461
pubmed: 32780629
Nutrients. 2019 Jun 30;11(7):
pubmed: 31262054
J Proteome Res. 2019 May 3;18(5):2228-2240
pubmed: 30892045
Front Genet. 2020 Oct 15;11:590369
pubmed: 33193730
Nutr Rev. 2020 Jun 1;78(6):459-464
pubmed: 31774508
Can Fam Physician. 2020 Feb;66(2):117-125
pubmed: 32060194
Nutrients. 2019 May 30;11(6):
pubmed: 31151228
Nutr Metab Cardiovasc Dis. 2018 Jul;28(7):698-706
pubmed: 29778565
Nutrients. 2020 Feb 28;12(3):
pubmed: 32121111
Obes Res Clin Pract. 2019 Jul - Aug;13(4):408-415
pubmed: 31302012
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Cell Metab. 2018 Jun 05;27(6):1222-1235.e6
pubmed: 29874567
Ann Med. 2020 Aug;52(5):147-161
pubmed: 32519900
Cell Metab. 2019 Sep 3;30(3):462-476.e6
pubmed: 31471173
Mult Scler Relat Disord. 2018 Jul;23:33-39
pubmed: 29753994
Br J Nutr. 2016 Mar 28;115(6):951-9
pubmed: 26819200
Nutrients. 2020 May 12;12(5):
pubmed: 32408718
Nutrients. 2020 Dec 08;12(12):
pubmed: 33302500
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Nutrients. 2019 Jan 23;11(2):
pubmed: 30678028
Am J Clin Nutr. 2020 Mar 1;111(3):503-514
pubmed: 31879752
Cell Metab. 2018 Jun 05;27(6):1212-1221.e3
pubmed: 29754952
J Clin Endocrinol Metab. 2021 Mar 8;106(3):902-911
pubmed: 33319233
J Physiol Pharmacol. 2018 Oct;69(5):
pubmed: 30683819
Clin Nutr. 2021 Apr;40(4):1788-1799
pubmed: 33139084
Nutrition. 2020 Nov - Dec;79-80:110974
pubmed: 32947129
Exp Clin Endocrinol Diabetes. 2017 Oct;125(9):618-624
pubmed: 28407662
Nutrients. 2019 Mar 20;11(3):
pubmed: 30897855
Diabetologia. 2020 Nov;63(11):2253-2259
pubmed: 32761356
Nutrition. 2020 Sep;77:110801
pubmed: 32428841